Epigenomics AG Stock Deutsche Boerse AG
Stocks
ECX
DE000A11QW50
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.785 EUR | -1.92% |
|
+9.51% | -4.03% |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 763K 872K 704K 651K 1.24M 83.25M 1.26M 8.43M 3.3M 40.88M 3.27M 3.2M 142M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.73M 13.41M 10.82M 10.01M 19M 1.28B 19.31M 130M 50.78M 629M 50.34M 49.25M 2.18B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +9.51% | - | - | 875K | |
| +5.67% | +3.89% | +118.98% | +150.11% | 4.48B | |
| +8.13% | +2.88% | +82.73% | +260.93% | 3.23B | |
| +1.31% | -3.10% | -29.71% | -41.05% | 1.94B | |
| +2.10% | +1.39% | +119.60% | -39.64% | 1.91B | |
| +5.66% | -0.27% | +43.54% | +188.50% | 1.42B | |
| -3.54% | -5.05% | -12.38% | +40.25% | 852M | |
| +3.65% | -1.16% | +116.30% | -50.99% | 850M | |
| +1.15% | -14.62% | -4.57% | - | 447M | |
| -1.21% | -2.16% | -37.45% | -18.98% | 479M | |
| Average | +2.10% | -2.34% | +44.12% | +61.14% | 1.73B | |
| Weighted average by Cap. | +4.25% | +0.18% | +70.57% | +106.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.43K 22.13K 20.48K 38.87K 2.62M 39.52K 265K 104K 1.29M 103K 101K 4.45M |
| Net income | -3.35M -3.83M -3.09M -2.86M -5.43M -366M -5.52M -37.02M -14.51M -180M -14.38M -14.07M -622M | -314K -359K -290K -268K -509K -34.26M -517K -3.47M -1.36M -16.82M -1.35M -1.32M -58.28M |
| Net Debt | 10.46M 11.95M 9.64M 8.92M 16.93M 1.14B 17.21M 115M 45.26M 560M 44.87M 43.9M 1.94B | 10.97M 12.54M 10.11M 9.36M 17.76M 1.2B 18.06M 121M 47.48M 588M 47.06M 46.05M 2.04B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ECX Stock
- ECX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
